Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis

Journal of Hepatology

Volumn 55, Issue 4, 2011, Pages 820-827

  Lucena, M I ^a,b   Kaplowitz, N ^c   Hallal, H ^d   Castiella, A ^e   Garcia Bengoechea M ^f   Otazua, P ^g   Berenguer, M ^b,h   Fernandez, M C ⁱ   Planas, R ^b,j   Andrade, R J ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Servicio Ap Digestivo   (Spain)

^e HOSPITAL DE MENDARO   (Spain)

^f Hospital Nuestra Senora de Aranzazu   (Spain)

^g H Alto Deba   (Spain)

^h Servicio Ap Digestivo   (Spain)

ⁱ Servicio de Farmacología Clínica   (Spain)

^j HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

more..

Author keywords

Autoimmune hepatitis; Class effect; Cross sensitivity; Drug induced liver injury; Hepatotoxicity; Rechallenge; Second DILI episode

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AMISULPRIDE; AMLODIPINE; AMOXICILLIN PLUS CLAVULANIC ACID; ATORVASTATIN; AZATHIOPRINE; CIPROFLOXACIN; CLOZAPINE; CYPROTERONE ACETATE; DILTIAZEM; DOXAZOSIN; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; ETANERCEPT; EZETIMIBE; FLUINDOSTATIN; FLURAZEPAM; FLUTAMIDE; GLIMEPIRIDE; GLYCERYL TRINITRATE; LORAZEPAM; METFORMIN; METHOTREXATE; MOXIFLOXACIN; OLANZAPINE; OMEPRAZOLE; PREDNISONE; PROPAFENONE; SIMVASTATIN; URSODEOXYCHOLIC ACID;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC BRONCHITIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; DEMOGRAPHY; DIABETES MELLITUS; DRUG WITHDRAWAL; DYSPEPSIA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOLLOW UP; HEART INFARCTION; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; LIVER CELL DAMAGE; MALE; PRIORITY JOURNAL; PRURITUS; RESPIRATORY TRACT INFECTION; RHEUMATOID ARTHRITIS; TOXIC HEPATITIS; URINARY TRACT INFECTION; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTI-INFECTIVE AGENTS; ANTICHOLESTEREMIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTIPSYCHOTIC AGENTS; ANTIRHEUMATIC AGENTS; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REGISTRIES; SPAIN;

EID: 79960941531     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.12.041     Document Type: Article

References (42)

1. S. Verma, and N. Kaplowitz Diagnosis, management and prevention of drug-induced liver injury Gut 58 2009 1555 1564
2. P.B. Watkins Biomarkers for the diagnosis and management of drug-induced liver injury Semin Liver Dis 29 2009 393 399
3. M.I. Lucena, A. Carvajal, R.J. Andrade, and A. Velasco Antidepressant-induced hepatotoxicity Expert Opin Drug Saf 2 2003 249 262
4. M.T. Hagley, R.L. Benak, and D.T. Hulisz Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity Ann Pharmacother 26 1992 780 781
5. M. Andrejak, T. Davion, J.L. Gineston, and J.P. Capron Cross hepatotoxicity between non-steroidal anti-inflammatory drugs Br Med J 295 1987 180 181 (Pubitemid 17101020)
6. W.L. Isley Hepatotoxicity of thiazolidinediones Expert Opin Drug Saf 2 2003 581 586
7. H. Foo, and T. Gottlieb Lack of cross-hepatotoxicity between voriconazole and posaconnazole Clin Infect Dis 45 2007 803 805
8. A. Nakad, L. Bataille, V. Hamoir, C. Sempoux, and Y. Horsmans Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin Lancet 353 1999 1763 1764 (Pubitemid 29240380)
9. M. Takeda, I. Okamoto, M. Fukuoka, and K. Nakagawa Successful Treatment With Erlotinib After Gefitinib-Related Severe Hepatotoxicity J Clin Oncol 28 2010 e273 e274
10. Y. Horsmans, and A.P. Geubel Amoxycillin-clavulanic acid-erythromycin cross-liver toxicity: a case report J Hepatol 21 1994 91 912
11. M.I. Lucena, R.J. Andrade, N. Kaplowitz, M. García-Cortes, M.C. Fernández, and M. Romero-Gomez Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex Hepatology 49 2009 2001 2009
12. C. Benichou, G. Danan, and A. Flahault Causality assessment of adverse reactions to drugs. II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge J Clin Epidemiol 46 1993 1331 1336 (Pubitemid 23333874)
13. C. Benichou Criteria of drug-induced liver disorders. Report of an international consensus meeting J Hepatol 11 1990 272 276
14. R.J. Fontana, L.B. Seeff, R.J. Andrade, E. Björnsson, C.P. Day, and J. Serrano Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop Hepatology 52 2010 730 742
15. F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, and E.L. Cancado International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938 (Pubitemid 29514229)
16. E.M. Hennes, M. Zeniya, A.J. Czaja, A. Pares, G.N. Dalekos, and E.L. Krawitt Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 2008 169 176 (Pubitemid 351975541)
17. R. Temple Hy's law predicting serious hepatotoxicity Pharmacoepidemiol Drug Saf 15 2006 241 243
18. A.C. Goldberg, P.L. Bittencourt, B. Mougin, E.L.R. Canado, G. Porta, and F. Carrilho Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus Hum Immunol 62 2001 165 169 (Pubitemid 32171655)
19. M. Miquel, A. Soler, A. Vaque, I. Ojanguren, J. Costa, and R. Planas Suspected cross-hepatotoxicity of flutamide and cyproterone acetate Liver Int 27 2007 1144 1147 (Pubitemid 47399450)
20. G.P. Aithal, P.B. Watkins, R.J. Andrade, D. Larrey, M. Molokhia, and H. Takikawa Case definition and phenotype standardization in drug-induced liver injury Clin Pharmacol Ther 89 2011 806 815
21. C.S. Seitz, P. Pfeuffer, P. Raith, E.B. Bröcker, and A. Trautmann Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents Ann Allergy Asthma Immunol 97 2006 698 702 (Pubitemid 44851471)
22. A.J. Remy, D. Larrey, G.P. Pageaux, J. Ribstein, J. Ramos, and H. Michel Cross hepatotoxicity between tricyclic antidepressants and phenothiazines Eur J Gastroenterol Hepatol 7 1995 373 376
23. M.L. Hautekeete, N. Bourgeois, P. Potvin, L. Duville, H. Reynaert, and G. Devis Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine Gastroenterology 103 1992 1925 1927
24. D.D. Christ, H. Satoh, J.G. Kenna, and L.R. Pohl Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane Drug Metab Dispos 16 1988 135 140 (Pubitemid 18057109)
25. D. Larrey Drug-induced liver diseases J Hepatol 32 2000 77 88 (Pubitemid 30123626)
26. R.J. Andrade, M.I. Lucena, M.C. Fernandez, G. Peláez, K. Patchkoria, and E. García-Ruiz Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period Gastroenterology 129 2005 512 521 (Pubitemid 41096639)
27. S. Nori, C. Nebesio, R. Brashear, and J.B. Travers Moxifloxacin associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure Arch Dermatol 140 2004 1537 1538 (Pubitemid 39627455)
28. R.J. Andrade, M. Robles, E. Ulzurrun, and M.I. Lucena Drug-induced liver injury: insights from genetic studies Pharmacogenomics 10 2009 1467 1487
29. S. Mallal, D. Nolan, C. Witt, G. Masel, A.M. Martin, and C. Moore Association between presence of HLA-B5701, HLA-DR7 and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir Lancet 359 2002 727 732 (Pubitemid 34215071)
30. A.K. Daly, P.T. Donaldson, P. Bhatnagar, Y. Shen, I. Pe'er, and A. Floratos HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin Nat Genet 41 2009 816 819
31. M.I. Lucena, M. Molokhia, Y. Shen, T.J. Urban, G.P. Aithal, and R.J. Andrade Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles Gastroenterology 2011 10.1053/j.gastro.2011.04.001
32. R. Schey, Y. Avni, R. Bruck, and H. Shirin History of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity Ann Pharmacother 35 2001 1142 1143 (Pubitemid 32880039)
33. J.B. Singer, S. Lewitzky, E. Leroy, F. Yang, X. Zhao, and L. Klickstein A genowe wide study identifies HLA alleles associated with lumiracoxib-related liver injury Nat Genet 42 2010 711 714
34. M.M. Hoeper Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy? Eur Respir J 34 2009 529 530
35. P.B. Watkins, L.M. Dube, K. Walton-Bowen, C.M. Cameron, and L.E. Kasten Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma Drug Saf 30 2007 805 815 (Pubitemid 47347353)
36. M.I. Lucena, R.J. Andrade, L. Rodrigo, J. Salmeron, A. Alvarez, and M.A. Lopez-Garrido Trovafloxacin-induced acute hepatitis Clin Infect Dis 30 2000 400 401 (Pubitemid 30131558)
37. W.M. Lee, D. Larrey, R. Olsson, J.H. Lewis, M. Keisu, and L. Auclert Hepatic findings in long-term clinical trials of ximelagatran Drug Saf 28 2005 351 370 (Pubitemid 40545769)
38. C. Lammert, S. Einarsson, C. Saha, A. Niklasson, E. Bjornsson, and N. Chalasani Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals Hepatology 47 2008 2003 2009 (Pubitemid 351945567)
39. A.J. Czaja Current concepts in autoimmune hepatitis Ann Hepatol 4 2005 6 24
40. E. Björnsson, and L. Davidsdottir The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice J Hepatol 50 2009 511 517
41. E. Björnsson, J. Talwalkar, S. Treeprasertsuk, P.S. Kamath, N. Takahashi, and S. Sanderson Drug-induced autoimmune hepatitis: clinical characteristics and prognosis Hepatology 51 2010 2040 2048
42. M.W. Russo, M. Scobey, and H.L. Bonkovsky Drug-induced liver injury associated with statins Semin Liver Dis 29 2009 412 422